Medpace Holdings, Inc.
For the period ended Sep 30, 2026. Filed Oct 22, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 22, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
During the three months ended September 30, 2026, no director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:
| Action | Date | Trading Arrangement | Total Shares to be Purchased or Sold | Duration/Expiration Date | ||
| Rule 10b5-1* | Non-Rule 10b5-1** | |||||
|---|---|---|---|---|---|---|
| August J. Troendle, Chief Executive Officer, President and Chairman of the Board | Adopt | July 27, 2026 [1] | X | Up to 307,959 shares to be sold | Good until cancelled | |
| Susan E. Burwig, Executive Vice President, Operations | Adopt | July 27, 2026 [2] | X | Up to 7,500 shares to be sold | The earlier of until cancelled or 180 days from the placement of the limit order | |
| Kevin M. Brady, Chief Financial Officer and Treasurer | Adopt | August 20, 2026 [3] | X | Up to 3,400 shares to be sold | The earlier of until cancelled or 180 days from the placement of the limit order | |
| * | Intended to satisfy the affirmative defense of Rule 10b5-1(c). |
|---|---|
| ** | Not intended to satisfy the affirmative defense of Rule 10b5-1(c). |
[1] On July 27, 2026, Mr. Troendle placed a limit order to sell up to 307,959 shares. Mr. Troendle modified the limit price on August 20, 2026.
[2] On July 27, 2026, Ms. Burwig placed a limit order to sell up to 7,500 shares.
[3] On August 20, 2026, Mr. Brady placed a limit order to sell up to 3,400 shares issued to him pursuant to his contemporaneous exercise of stock options.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.